Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve 1) Quarterly unaudited financial results for the quarter ended June 30, 2025 (both standalone & consolidated); 2) Recommendation of Final Dividend for the FY 2024-25 for approval of shareholders; 3) Convening the Annual General Meeting of the Company; and 4) Fixation of record date for determining the eligibility of shareholders entitled for the Final Dividend.